223 related articles for article (PubMed ID: 21622622)
1. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
Shultz JC; Goehe RW; Murudkar CS; Wijesinghe DS; Mayton EK; Massiello A; Hawkins AJ; Mukerjee P; Pinkerman RL; Park MA; Chalfant CE
Mol Cancer Res; 2011 Jul; 9(7):889-900. PubMed ID: 21622622
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.
Shultz JC; Goehe RW; Wijesinghe DS; Murudkar C; Hawkins AJ; Shay JW; Minna JD; Chalfant CE
Cancer Res; 2010 Nov; 70(22):9185-96. PubMed ID: 21045158
[TBL] [Abstract][Full Text] [Related]
3. An intron enhancer recognized by splicing factors activates polyadenylation.
Lou H; Gagel RF; Berget SM
Genes Dev; 1996 Jan; 10(2):208-19. PubMed ID: 8566754
[TBL] [Abstract][Full Text] [Related]
4. SRp30a (ASF/SF2) regulates the alternative splicing of caspase-9 pre-mRNA and is required for ceramide-responsiveness.
Massiello A; Chalfant CE
J Lipid Res; 2006 May; 47(5):892-7. PubMed ID: 16505493
[TBL] [Abstract][Full Text] [Related]
5. Interaction of hnRNPA1/A2 and DAZAP1 with an Alu-derived intronic splicing enhancer regulates ATM aberrant splicing.
Pastor T; Pagani F
PLoS One; 2011; 6(8):e23349. PubMed ID: 21858080
[TBL] [Abstract][Full Text] [Related]
6. hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing.
Goehe RW; Shultz JC; Murudkar C; Usanovic S; Lamour NF; Massey DH; Zhang L; Camidge DR; Shay JW; Minna JD; Chalfant CE
J Clin Invest; 2010 Nov; 120(11):3923-39. PubMed ID: 20972334
[TBL] [Abstract][Full Text] [Related]
7. Interactions of SR45, an SR-like protein, with spliceosomal proteins and an intronic sequence: insights into regulated splicing.
Day IS; Golovkin M; Palusa SG; Link A; Ali GS; Thomas J; Richardson DN; Reddy AS
Plant J; 2012 Sep; 71(6):936-47. PubMed ID: 22563826
[TBL] [Abstract][Full Text] [Related]
8. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
Arrisi-Mercado P; Romano M; Muro AF; Baralle FE
J Biol Chem; 2004 Sep; 279(38):39331-9. PubMed ID: 15247216
[TBL] [Abstract][Full Text] [Related]
9. Role for Fox-1/Fox-2 in mediating the neuronal pathway of calcitonin/calcitonin gene-related peptide alternative RNA processing.
Zhou HL; Baraniak AP; Lou H
Mol Cell Biol; 2007 Feb; 27(3):830-41. PubMed ID: 17101796
[TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
[TBL] [Abstract][Full Text] [Related]
11. SRSF1 regulates the assembly of pre-mRNA processing factors in nuclear speckles.
Tripathi V; Song DY; Zong X; Shevtsov SP; Hearn S; Fu XD; Dundr M; Prasanth KV
Mol Biol Cell; 2012 Sep; 23(18):3694-706. PubMed ID: 22855529
[TBL] [Abstract][Full Text] [Related]
12. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.
Gonçalves V; Henriques AF; Pereira JF; Neves Costa A; Moyer MP; Moita LF; Gama-Carvalho M; Matos P; Jordan P
RNA; 2014 Apr; 20(4):474-82. PubMed ID: 24550521
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic factors control the unproductive splicing of SC35 terminal intron.
Dreumont N; Hardy S; Behm-Ansmant I; Kister L; Branlant C; Stévenin J; Bourgeois CF
Nucleic Acids Res; 2010 Mar; 38(4):1353-66. PubMed ID: 19965769
[TBL] [Abstract][Full Text] [Related]
15. hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
Talukdar I; Sen S; Urbano R; Thompson J; Yates JR; Webster NJ
PLoS One; 2011; 6(11):e27869. PubMed ID: 22132154
[TBL] [Abstract][Full Text] [Related]
16. An intronic splicing enhancer binds U1 snRNPs to enhance splicing and select 5' splice sites.
McCullough AJ; Berget SM
Mol Cell Biol; 2000 Dec; 20(24):9225-35. PubMed ID: 11094074
[TBL] [Abstract][Full Text] [Related]
17. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
D'Souza I; Schellenberg GD
J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
[TBL] [Abstract][Full Text] [Related]
19. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
20. Exon 9 skipping of apoptotic caspase-2 pre-mRNA is promoted by SRSF3 through interaction with exon 8.
Jang HN; Lee M; Loh TJ; Choi SW; Oh HK; Moon H; Cho S; Hong SE; Kim DH; Sheng Z; Green MR; Park D; Zheng X; Shen H
Biochim Biophys Acta; 2014 Jan; 1839(1):25-32. PubMed ID: 24321384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
